Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Free Cash Flow: 2016-2024

Historic Free Cash Flow for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to -$100.7 million.

  • Solid Biosciences' Free Cash Flow fell 42.73% to -$29.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$100.7 million, marking a year-over-year decrease of 5.19%. This contributed to the annual value of -$100.7 million for FY2024, which is 5.19% down from last year.
  • Solid Biosciences' Free Cash Flow amounted to -$100.7 million in FY2024, which was down 5.19% from -$95.7 million recorded in FY2023.
  • Solid Biosciences' Free Cash Flow's 5-year high stood at -$57.5 million during FY2020, with a 5-year trough of -$101.0 million in FY2022.
  • Over the past 3 years, Solid Biosciences' median Free Cash Flow value was -$100.7 million (recorded in 2024), while the average stood at -$99.1 million.
  • Per our database at Business Quant, Solid Biosciences' Free Cash Flow spiked by 40.79% in 2020 and then plummeted by 37.47% in 2021.
  • Over the past 5 years, Solid Biosciences' Free Cash Flow (Yearly) stood at -$57.5 million in 2020, then crashed by 37.47% to -$79.0 million in 2021, then dropped by 27.77% to -$101.0 million in 2022, then rose by 5.24% to -$95.7 million in 2023, then dropped by 5.19% to -$100.7 million in 2024.